Australia markets open in 3 hours 49 minutes

Outlook Therapeutics, Inc. (OTLK)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
8.75+0.13 (+1.51%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/09/2023
30/09/2022
30/09/2021
30/09/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
21,120
26,453
42,331
38,958
26,342
Selling general and administrative
26,642
26,673
20,740
12,769
9,971
Total operating expenses
47,761
53,126
63,071
51,727
36,313
Operating income or loss
-47,761
-53,126
-63,071
-51,727
-36,313
Interest expense
-
1,560
1,487
936.127
1,756
Total other income/expenses net
-4,812
-4,294
-1,491
-498.486
-441.976
Income before tax
-51,496
-58,980
-66,049
-53,161
-38,511
Income tax expense
-
2.8
2.8
2
-3,272
Income from continuing operations
-51,498
-58,983
-66,052
-53,163
-35,239
Net income
-51,498
-58,983
-66,052
-53,163
-35,239
Net income available to common shareholders
-51,498
-58,983
-66,052
-53,163
-48,874
Basic EPS
-0.24
-0.24
-0.31
-0.35
-0.67
Diluted EPS
-0.24
-0.24
-0.31
-0.35
-0.67
Basic average shares
250,177
250,177
212,079
152,676
72,556
Diluted average shares
250,177
250,177
212,079
152,676
72,556